ALSERepository of Iași University of Life Sciences, ROMANIA

Efficacy of two anthelmintic products on strongyles in horses from stud farms in Romania

Show simple item record

dc.contributor.author Buzatu, Marius-Cătălin
dc.contributor.author Mitrea, Ioan-Liviu
dc.contributor.author Miron, Liviu-Dan
dc.contributor.author Ioniță, Mariana
dc.date.accessioned 2025-02-19T09:13:21Z
dc.date.available 2025-02-19T09:13:21Z
dc.date.issued 2015
dc.identifier.citation Buzatu, M. C., I. L. Mitrea, L. Miron, Mariana Ioniță. 2015. “Efficacy of two anthelmintic products on strongyles in horses from stud farms in Romania”. Agriculture and Agricultural Science Procedia 6: 293–298. DOI: 10.1016/j.aaspro.2015.08.075 en_US
dc.identifier.issn 2210-7843
dc.identifier.uri https://www.sciencedirect.com/science/article/pii/S2210784315002089
dc.identifier.uri https://repository.iuls.ro/xmlui/handle/20.500.12811/5138
dc.description.abstract Nematodes belonging to the group of equine strongyles have a huge impact on equine health. Studies in horse establishments world-wide have shown a tremendous occurrence of these parasites under largely different geographic and climatic conditions. Accordingly, decades of strongyle control have been based on regular and frequent preventive treatments with anthelmintics and, subsequently, this has led to increasing levels of anthelmintic resistance. Therefore, it is essential that investigations into the efficacy of current anthelmintics in different locations are performed to help future reliable control programmes. This paper reports preliminary data of a survey conducted in Romania to evaluate the efficacy of two commonly used anthelmintics (fenbendazole - FBZ and ivermectin - IVM) against horse strongyles, using a faecal egg count reduction test (FECRT). Horses with a strongyle faecal egg count (FEC) of ≥50 eggs per gram (EPG) were enrolled into the study. The anthelmintic efficacy was determined by calculating the percentage of reduction in FEC between the group mean at Day 0 and Days 14 post-treatment. Individual strongyle faecal egg count reduction tests (n=137) were performed on three stud farms (R, S, C) in which 108 and 29 horses were administered ivermectin and fenbendazole, respectively. The results of the study have shown that the efficacy was within the expected range with no signs of anthelmintic resistance for IVM (98.2-100%). However, FBZ resistance was suspected in one stud (the group mean FECR of 75.4%). Thus, further studies are planned to investigate extension of the anthelmintic resistance in horse parasites including an increased number and different horse establishments in Romania, in order to design realistic control programmes carrying a limited risk of selection for anthelmintic resistance and improve overall health of the horses. en_US
dc.language.iso en en_US
dc.publisher Elsevier B.V. en_US
dc.rights Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject anthelmintic drugs en_US
dc.subject efficacy en_US
dc.subject strongyles en_US
dc.subject horses en_US
dc.subject Romania en_US
dc.subject stud farms en_US
dc.title Efficacy of two anthelmintic products on strongyles in horses from stud farms in Romania en_US
dc.type Article en_US
dc.author.affiliation Marius Catalin Buzatu, Ioan Liviu Mitrea, Mariana Ionita, University of Agronomic Sciences and Veterinary Medicine of Bucharest, Faculty of Veterinary Medicine, Spl. Independentei, 105, Bucharest, 050097, Romania
dc.author.affiliation Liviu Miron, University of Agricultural Sciences and Veterinary Medicine of Iasi, Faculty of Veterinary Medicine, Aleea Mihail Sadoveanu, 8, 700489, Iaşi, Romania
dc.publicationName Agriculture and Agricultural Science Procedia
dc.volume 6
dc.issue
dc.publicationDate 2015
dc.startingPage 293
dc.endingPage 298
dc.identifier.doi 10.1016/j.aaspro.2015.08.075


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)